Please use this identifier to cite or link to this item: https://doi.org/10.1038/cddis.2017.513
Title: Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
Authors: Xia H.
Hui K.M. 
Keywords: acetylsalicylic acid
chemokine
clopidogrel
growth arrest and DNA damage inducible protein 45
long chain fatty acid coenzyme A ligase
long chain fatty acid coenzyme A ligase 4
nonsteroid antiinflammatory agent
oxidoreductase
protein HTATIP2
sorafenib
stromal cell derived factor 1 alpha
unclassified drug
acetylsalicylic acid
antineoplastic agent
antineoplastic activity
bleeding
cancer adjuvant therapy
cancer prevention
cancer recurrence
cancer risk
chronic hepatitis B
chronic liver disease
disease course
disease free survival
drug effect
drug potentiation
gene expression
human
inflammation
liver cell carcinoma
liver fibrosis
liver injury
liver resection
metastasis
metastatic colorectal cancer
nonhuman
Note
overall survival
priority journal
protein expression
randomized controlled trial (topic)
risk reduction
thrombocyte
treatment outcome
upregulation
animal
liver tumor
metabolism
pathology
Animals
Antineoplastic Agents
Aspirin
Humans
Liver Neoplasms
Issue Date: 2017
Publisher: Nature Publishing Group
Citation: Xia H., Hui K.M. (2017). Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer. Cell Death and Disease 8 (10) : e3112. ScholarBank@NUS Repository. https://doi.org/10.1038/cddis.2017.513
Abstract: [No abstract available]
Source Title: Cell Death and Disease
URI: https://scholarbank.nus.edu.sg/handle/10635/174416
ISSN: 2041-4889
DOI: 10.1038/cddis.2017.513
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_cddis_2017_513.pdf452.63 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

6
checked on Apr 4, 2021

Page view(s)

51
checked on Apr 9, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.